Description
Leprosy is present in more than 100 countries, where it remains a major cause of peripheral neuropathy and disability. The article concludes that a global leprosy coalition is needed to achieve zero transmission.
Multidrug Therapy for Leprosy: A Game Changer on the Path to Elimination
Related Items
-
DocumentlockLeprosy Post-exposure Prophylaxis with Single-dose Rifampicin (LPEP): An International Feasibility Programme -
DocumentlockLeprosy Diagnostic Test Development As a Prerequisite Towards Elimination: Requirements from the User’s Perspective -
DocumentlockAn Innovative Approach to Screening and Chemoprophylaxis among Contacts of Leprosy Patients in Low Endemic Settings: Experiences from Cambodia -
DocumentlockMinimal Essential Data to Document Contact Tracing and Single Dose Rifampicin (SDR) for Leprosy Control in Routine Settings: A Practical Guide